ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

ImpactGuru Fundraiser Initiated to Cover Rs 16 Crore Zolgensma Cost of 3-month-old

Mumbai (Maharashtra) [India], November 17 (ANI/NewsVoir): Mumbai based Priyanka and Mihir Kamat have taken to crowdfunding on ImpactGuru.com to cover the cost of Zolgensma therapy as their 3-month-old baby Teera is diagnosed with Spinal Muscular Atrophy (SMA) Type 1.

ANI Nov 17, 2020 16:09 IST googleads

Teera Kamat

Mumbai (Maharashtra) [India], November 17 (ANI/NewsVoir): Mumbai based Priyanka and Mihir Kamat have taken to crowdfunding on ImpactGuru.com to cover the cost of Zolgensma therapy as their 3-month-old baby Teera is diagnosed with Spinal Muscular Atrophy (SMA) Type 1.
SMA is a rare genetic disease that attacks the baby's nerves and muscles, and as it progresses, makes it extremely difficult for the child to carry out basic activities like sit up, lift their head, swallow milk, and even breathe. SMA is currently the leading genetic cause of infant death worldwide, and it affects 1 in 10,000 babies.
In a heartfelt appeal Teera's parents Priyanka and Mihir Kamat said, "Our brand new bundle of joy is fighting for her life. As of now, there are no treatment options available in India for this invisible killer. Our only hope for Teera to have a normal life is to be able to import Zolgensma, a one-time gene replacement therapy, which in her current state could be a potential "cure". Zolgensma is Teera's best shot at quality life, and not just an extended life span. Other treatment options need recurring lifetime care with significant annual cost."
"Commercially Zolgensma is available in the USA for approximately USD 2.1 million (Rs 16 crores). We are unable to bear this steep cost, hence we request you to please donate with your heart so we can save our Teera's life. Please find the link here impactgu.ru/teera We see the hope in her eyes and it gives us all the strength we need to wake up day by day and fight the good fight to save our baby girl," Teera's parents Priyanka and Mihir Kamat added.
"It is heartening to witness that in 12 days, 2450 donors have come forward and cumulatively contributed over Rs 1 crore to support Teera's parents in their journey of saving their child. We hope more families come forward to utilize our healthcare financing platform in their time of need to get the best available treatment for critical illnesses," said Piyush Jain, Co-founder and CEO, ImpactGuru.com
Crowdfunding is an alternative method of raising funds online for medical expenses, with the patient (or his/her friends or family) primarily relying on social media networks to mobilize donors to finance the relevant medical bills.
Follow Teera's Fight with SMA on:
Instagram: www.instagram.com/teera_fights_sma
Facebook: www.facebook.com/TeeraFightsSMA
Twitter: twitter.com/TeeraFightsSma
ImpactGuru.com is India's leading healthcare financing platform for patients and raises money online for medical expenses via online crowdfunding such as COVID-19, cancer, transplants, and accidents. It aggregates a large number of online payments to allow any individual requiring financial assistance to raise funds for any social cause.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Get the App

What to Read Next

Business

South Tamil Nadu First: Nonsurgical Interventional Radiology

South Tamil Nadu First: Nonsurgical Interventional Radiology

Tirunelveli (Tamil Nadu) [India], March 10: Marking a significant medical milestone and a first in South Tamil Nadu, Kauvery Hospital has successfully treated a 51-year-old woman with severe symptomatic uterine fibroids using a minimally invasive procedure known as Bilateral Uterine Artery Embolisation (UAE). This advanced treatment enabled preservation of the uterus while ensuring rapid recovery. The patient was discharged within 24 hours, and at her seven-day follow-up, imaging confirmed complete absence of blood flow to the fibroid, with no pain and no per vaginal bleeding.

Read More
Business

“Before You Throw Colours, Heal the Ones Within”

“Before You Throw Colours, Heal the Ones Within”

Mumbai (Maharashtra) [India], March 2: We will throw colours. We will laugh. We will click pictures in white outfits. But will we pause?

Read More
Business

Indraprastha Apollo Hospitals Launches Varian Edge Radiosurgery

Indraprastha Apollo Hospitals Launches Varian Edge Radiosurgery

New Delhi [India], February 25: Indraprastha Apollo Hospitals has launched the Varian Edge® Radiosurgery System with Hyperarc Technology, strengthening its advanced cancer care capabilities and expanding treatment options for complex and hard-to-reach tumours.

Read More
Business

SHLOK Dermatology & Wellness Launches in Kokapet

SHLOK Dermatology & Wellness Launches in Kokapet

Hyderabad (Telangana) [India], February 24: Hyderabad's growing healthcare landscape witnessed a significant addition with the grand launch of Shlok Dermatology and Wellness on 22nd February, 2026, at Kokapet, Hyderabad. Founded by renowned dermatologist Dr. Manisha Mareddy, the centre marks the beginning of a new era in evidence-based, proportion-led dermatology in the city.

Read More
Business

Indigenous CAR-T Therapy Signals New Phase for India’s Cancer

Indigenous CAR-T Therapy Signals New Phase for India’s Cancer

New Delhi [India], February 19: When Ms. Arora's cancer returned, the emotional weight of relapse was immediate. Having already undergone standard lines of treatment for non-Hodgkin's lymphoma (NHL) after her diagnosis in 2022, she now faced a narrower set of options--each complex, each uncertain. "I remember feeling that the ground had shifted again," she says. "But my medical team walked me through the available options, and we decided to move forward with an indigenous CAR-T therapy." Today, her story forms part of a broader shift unfolding in India's oncology ecosystem--one marked not just by clinical innovation, but by homegrown scientific capability.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.